Search

Your search keyword '"Tomohiro Yamasaki, MD"' showing total 2 results
Start Over Author "Tomohiro Yamasaki, MD"
2 results on '"Tomohiro Yamasaki, MD"'

1. Aspiration After Sealing the Entrance by Stenting Is a Promising Method to Treat Subintimal Hematoma

Author

Akinori Sumiyoshi, MD, Astunori Okamura, MD, PhD, Mutsumi Iwamoto, MD, Hiroyuki Nagai, MD, Tomohiro Yamasaki, MD, Takamasa Tanaka, MD, Kohta Tanaka, MD, Katusomi Iwakura, MD, PhD, and Kenshi Fujii, MD, PhD

Subjects
acute coronary syndrome, complication, dissection, Diseases of the circulatory (Cardiovascular) system, RC666-701
Abstract

Creation of a distal re-entry site is widely performed to treat subintimal hematoma. However, this method has a risk of further vessel damage. The present aspiration technique after sealing the entry site by stenting is more promising because the hematoma can be reduced without additional vessel damage. (Level of Difficulty: Advanced.)

Published
2021
Full Text
View/download PDF

2. Cardioprotective Effects of VCP Modulator KUS121 in Murine and Porcine Models of Myocardial Infarction

Author

Yuya Ide, MD, Takahiro Horie, MD, PhD, Naritatsu Saito, MD, PhD, Shin Watanabe, MD, PhD, Chiharu Otani, MD, Yui Miyasaka, BSc, Yasuhide Kuwabara, MD, PhD, Tomohiro Nishino, MD, PhD, Tetsushi Nakao, MD, PhD, Masataka Nishiga, MD, PhD, Hitoo Nishi, MD, PhD, Yasuhiro Nakashima, MD, PhD, Fumiko Nakazeki, MD, PhD, Satoshi Koyama, MD, PhD, Masahiro Kimura, MD, Shuhei Tsuji, MD, Randolph Ruiz Rodriguez, MD, Sijia Xu, MD, Tomohiro Yamasaki, MD, Toshimitsu Watanabe, MD, Masamichi Yamamoto, PhD, Motoko Yanagita, MD, PhD, Takeshi Kimura, MD, PhD, Akira Kakizuka, MD, PhD, and Koh Ono, MD, PhD

Subjects
Diseases of the circulatory (Cardiovascular) system, RC666-701
Abstract

Summary: No effective treatment is yet available to reduce infarct size and improve clinical outcomes after acute myocardial infarction by enhancing early reperfusion therapy using primary percutaneous coronary intervention. The study showed that Kyoto University Substance 121 (KUS121) reduced endoplasmic reticulum stress, maintained adenosine triphosphate levels, and ameliorated the infarct size in a murine cardiac ischemia and reperfusion injury model. The study confirmed the cardioprotective effect of KUS121 in a porcine ischemia and reperfusion injury model. These findings confirmed that KUS121 is a promising novel therapeutic agent for myocardial infarction in conjunction with primary percutaneous coronary intervention. Key Words: ATP, ER stress, KUS121, myocardial infarction

Published
2019
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results